Key stats
About First Trust Nasdaq Pharmaceuticals ETF
Home page
Inception date
Sep 20, 2016
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
First Trust Advisors LP
Distributor
First Trust Portfolios LP
ISIN
US33738R8372
FTXH holds a concentrated basket of 30 highly liquid pharmaceutical stocks weighted according to various factors. While many funds perform a basic liquidity screen as part of their index construction and rebalancing, FTXH goes beyond the basic screen and uses liquidity for selection. The 30 most liquid pharmaceutical stocks in the US are chosen for inclusion in the index as determined by 3-month average daily traded volume. The selected constituents are then ranked and weighted on three different factors: 1) strong growth, as exhibited by 3-, 6-, 9-, and 12-month average price returns, 2) attractive value, evaluated by cash-flow-to-price, and 3) low volatility, based on historical price fluctuations. Single security weights are capped at 8%. The index is rebalanced quarterly and reconstituted annually.
Related funds
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Top 10 holdings
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
FTXH assets under management is 15.68 M USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
FTXH invests in stocks. See more details in our Analysis section.
FTXH expense ratio is 0.60%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, FTXH isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
Yes, FTXH pays dividends to its holders with the dividend yield of 1.58%.
FTXH shares are issued by AJM Ventures LLC
FTXH follows the Nasdaq US Smart Pharmaceuticals Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Sep 20, 2016.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.